优化FDA血:系统级定制室内辅助器件设计的案例研究
Canberk Yıldırım1, Kağan Uçak2, Ali Madayen3
1Department of Biomedical Engineering, Koc University, 34060, Istanbul, Turkey.
Annals of biomedical engineering
|September 9, 2025
概括
这项研究引入了设计心室辅助器件 (VAD) 的高效框架,显著减少了血液溶解和血湿区域. 这种新方法优化了VAD,使患者血液动力学变得更好,发育周期更短.
科学领域:
- 生物医学工程 生物医学工程
- 医疗器械设计 医疗器械设计
- 计算流体动力学的流体动力学.
背景情况:
- 心室辅助器件 (VAD) 的开发传统上依赖于计算流体动力学 (CFD),通常涉及漫长的试错过程.
- 目前对VAD的CFD优化方法耗时且资源密集,需要更高效的方法.
研究的目的:
- 开发和介绍一个新的,高效的VAD设计和优化框架.
- 在VAD开发中克服传统基于CFD的试错优化方法的局限性.
主要方法:
- 结合一块参数心血管模型与轮机械和叶片路径设计包,以实现系统级优化.
- 纳入了的水力动力损失,并根据实验数据和CFD模拟验证了框架.
- 启用了与生理学和设备相关目标的规范,以实现广泛的参数空间优化.
主要成果:
- 应用了对FDA基准血的优化,实现了叶片尖速度减少约32%,血液溶解减少约88%.
- 创建了一个替代设计,在保持基线压力和流量的同时,血湿面积减少了40%.
- 在的性能和设计效率方面取得了显著的改进.
结论:
- 拟议的框架通过缩短设计周期来提高VAD开发效率.
- 能够创建适合不同患者血液动力学的水力动力学优化.
- 优化VAD设计被提供为开源资源,用于未来的研究.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
263
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
263
01:29Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343